Preview

Innovative Medicine of Kuban

Advanced search

CAUSES OF GASTRIC CANCER RECURRENCES IN PATIENTS AFTER RADICAL SURGERY

Abstract

Gastric cancer is one the most serious oncological pathologies and it occupies the third position in the structure of oncological mortality. Latest achievements in surgery for gastric cancer are linked to extended lymph node dissection (D2), still, long-term results depend on carcinoma extension, regional lymph node involvement, tumor invasion depth and differentiation. Background: study survival in the patients treated for locally advanced gastric cancer regarding lymph node dissection volume and specific tumor characteristics. Materials and methods: applying Kaplan-Meier method and variance analysis we studied long-term results of 662 patients with gastric cancer with minimal lymph node dissection (D1) in the control group and extended lymph node dissection (D2) in the main group depending on 10 different features of tumor stage. Results: while analyzing long-term results of treatment we defined authentic advantage in patients in the main group according to their total and non-recurrent 5-year survival rates, and the median in the control group was 32,0 months, and in the main group it was 46,0 months. Inherent effect of extended lymph node dissection (D2) was defined at the level of any tumor characteristics, meanwhile their impacts including stage, metastatic spread and regional lymph node invasion and low tumor differentiation had more massive influence on patient survival rate than extended lymph node dissection. Conclusions: surgery for gastric cancer should be accompanied by extended lymph node dissection (D2), and its impact is seen at any tumor clinic stage. The best observed treatment effect in patients with gastric cancer could be achieved while following therapy standards and diagnosing tumors at early stages.

About the Authors

A. G. Baryshev
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar Region; State Budget Higher Educational Institution 'Kuban State Medical University', Public Health Ministry of Russia
Russian Federation


V. A. Porhanov
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar Region; State Budget Higher Educational Institution 'Kuban State Medical University', Public Health Ministry of Russia
Russian Federation


A. J. Popov
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar Region
Russian Federation


A. N. Lischenko
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar Region
Russian Federation


N. V. Khachaturyan
State Public Health Budget Institution 'Scientific Research Institute - Ochapovsky Regional Clinic Hospital # 1, Public Health Ministry of Krasnodar Region; State Budget Higher Educational Institution 'Kuban State Medical University', Public Health Ministry of Russia
Russian Federation


D. A. Valyakis
State Budget Higher Educational Institution 'Kuban State Medical University', Public Health Ministry of Russia
Russian Federation


M. V. Bodnya
State Budget Higher Educational Institution 'Kuban State Medical University', Public Health Ministry of Russia
Russian Federation


References

1. Jacques F., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 // Int. J. Cancer. - 2015. - Vol. 136, № 5. - P. 359 - 386.

2. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2014 году. - Москва: Коллектив авторов МНИОИ им. П.А. Герцена. - 2016. - 250с.

3. Каприн, А.Д. Состояние онкологической помощи населению России в 2012 г. / А.Д. Каприн, В.В. Старинский, Г.В. Петрова. - М.: ФГБУ «МНИОИ им. П.А. Герцена» МЗ РФ, 2013. - 232 с.

4. Huang C.M. Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer / C.M. Huang, J.X. Lin, C.H. Zheng [et al.] // World J. Gastroentrerol. - 2009. - Vol. 15. - № 31. - P. 3926 - 3930.

5. Hundahl, S.A. Changing gastric cancer treatment in the United States and the pursuit of quality / S.A. Hundahl, H.J. Wanebo // European Journal of Surgical Oncology. - 2005. - Vol. 31. - № 6. - Р. 605 - 615.

6. Maruyama, K. Japanese classification of gastric carcinoma: points to be improved / K. Maruyama, M. Sasako, T. Kinoshita [et al.] // Surg Therapy. - 1996. -Vol. 75. - P. 277 - 282.

7. Moenig, S.P. Feasibility of sentinel node concept in gastric carcinoma: clinicopathological analysis of gastric cancer with solitary lymph node metastasis / S.P. Moenig, T. Luebke, S.E. Baldus [et al.] // Anticancer Res. - 2005. - Vol. 25. - № 2B. - P. 1349 - 1352.

8. Pacelli, F. Pancreas-preserving total gastrectomy for gastric cancer / F. Pacelli, V. Papa, G.B. Doglietto // 4-th International Gastric Cancer Congress. - New York, 2001. - P. 979 - 983.

9. Симонов, H.H. Факторы, определяющие эффективность лечения при местно-распространенном раке желудка / Н.Н. Симонов, В.Д. Чарторижский, О.Р. Мельников // Вопросы онкологии. - 1997. - Т. 43. - № 2. - С. 210 - 213.

10. Adachi, Y. Prognostic significance of the number of positive lymph nodes in gastric carcinoma / Y. Adachi, T. Kamakura, M. Mori [et al.] // Br J Surg. - 1994. - Vol. 81. - P. 414 - 416.

11. Adachi, Y. Most important lymph node information: in gastric cancer: multivariate prognostic study / Y. Adachi, N. Shiraishi, T. Suematsu [et al.] // Ann Surg Oncol. - 2000. - Vol. 7. - № 7. - P. 503 - 507.

12. Nashimoto, A. Gastric Cancer Surgical Study Group; Japan Clinical Oncology Group. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1 / A. Nashimoto, T. Nakajima, H. Furukawa, M. Kitamura, T. Kinoshita, Y. Yamamura [et al.] // J Clin Oncol. - 2003. - Vol. 21. - P. 2282 - 2287.

13. Roukos, D.H. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery / D.H. Roukos, P. Paraschou, M. Lorenz // Ann.Surg. Oncol. - 2000, Dec. - Vol. 7. - № 10. - P. 715 - 716.

14. Siewert, J.R. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Group / J.R. Siewert, K. Bottcher, H.J. Stein, J. D. Roder // Ann. Surg. -1998, Oct. - Vol. 228. - № 4. - P. 449 - 461.

15. Maruyama, K. Progress in gastric cancer surgery in Japan and its limits of radicality / K. Maruyama, K. Okabayashi, T. Kinoshita // World. J. Surg. - 1987. - Vol. 11. - № 4. - P.418 - 425.

16. Давыдов, М.И. Современная хирургия рака желудка: от D2 к D3 / М. И. Давыдов, И. Н. Туркин, Б. Е. Полоцкий // Материалы IX Российского онкологич. конгр. - М., 2005. - С. 41 - 43.

17. Msika, S. Population-based study of diagnosis, treatment and prognosis of gastric cancer / S. Msika, M. Tazi, J. Benhamiche [et al.] // Br J Surg. - 1997. - Vol. 84. - P. 1474 - 1478.

18. Maruyama, K. Lymph node metastases of gastric cancer. / K. Maruyama P. Gunven, K. Okabayaschi, M. Sasako, T. Kinoshita // Ann. Surg. - 1989. -Vol. 210. - № 5. - P. 596 - 602.

19. Maruyama, K. Surgical treatment for gastric cancer: the Japanese approach / K. Maruyama, M. Sasako, T. Kinoshita, T. Sano, H. Katai // Semin. Oncol. - 1996. -Vol. 23. - № 3. - P. 360 - 368.

20. Гланц, С. Медико-биологическая статистика / С. Гланц. - М.: Практика, 1998. - 459 с.


Review

For citations:


Baryshev A.G., Porhanov V.A., Popov A.J., Lischenko A.N., Khachaturyan N.V., Valyakis D.A., Bodnya M.V. CAUSES OF GASTRIC CANCER RECURRENCES IN PATIENTS AFTER RADICAL SURGERY. Innovative Medicine of Kuban. 2016;(4):8-14. (In Russ.)

Views: 298


ISSN 2541-9897 (Online)